AAM All Access Podcast - Dan Leonard speaks with Mary Beth Powers, President and CEO of CMMB.

Steven Selde

Director, Biosimilars Council
Steven Selde

Steven Selde is Director of the Biosimilars Council. This division of the Association for Accessible Medicines (AAM) educates the public and patients about the safety and effectiveness of biosimilars, focusing on access, the regulatory environment, reimbursement and legal affairs. Member organizations include manufacturers and stakeholders working to develop biosimilar products for the U.S. market. As Director, Steven works with leadership to identify issues affecting Biosimilars Council members’ interests and develop and implement advocacy strategies and tactics that effectively support those interests.

Prior to joining AAM, Steven was Assistant Director, Government Affairs, for the Ambulatory Surgery Center Association (ASCA). In this role he represented ambulatory surgery centers before Congress and federal agencies. Prior to his work with ASCA, he served as legislative counsel for Senator Deb Fischer (R., Neb.); there, he was responsible for developing and progressing the senator’s policy positions on health care, education, labor, Veterans Affairs and Indian Affairs. Steven developed and executed strategies to enact Senator Fischer’s legislation, including the Communities Helping Invest through Property and Improvements Needed for Veterans Act (H.R.5099/S.3364), Strong Families Act (S.1716) and Veterans Fair Debt Notice Act (S.2248), all signed into law.

Steven attended Creighton University School of Law and received his BA from Fordham University.

Latest Tweets

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.